You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mastocytosis, Systemic

Showing 1 - 25 of 8,222
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quality of Life and Disease-related Symptoms in Individuals With

Not yet recruiting
  • Mastocytosis, Systemic
  • No intervention
  • Stockholm, Sweden
  • +1 more
Sep 26, 2023

A Registry for Patients With Systemic Mastocytosis in China

Not yet recruiting
  • Systemic Mastocytoses
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Aug 24, 2023

    DALY on a Cohort of Patients With Indolent Systemic Mastocytosis

    Recruiting
    • Mastocytosis, Indolent Systemic
      • Toulouse, Haute-Garonne, France
        Centre de Référence des Mastocytoses, Service de Dermatologie, H
      Jun 19, 2023

      Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

      Not yet recruiting
      • Advanced Systemic Mastocytosis
      • (no location specified)
      Nov 2, 2022

      Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou

      Not yet recruiting
      • Systemic Mastocytosis With AHNMD
      • Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Aug 16, 2022

        Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

        Completed
        • Aggressive Systemic Mastocytosis
        • +3 more
        • Stanford, California
        • +10 more
        Jan 12, 2023

        SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)

        Recruiting
        • SSM
        • +3 more
        • CGT9486 Tablets
        • Placebo Tablets
        • Clearwater, Florida
        • +5 more
        Apr 14, 2022

        Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in

        Recruiting
        • Advanced Systemic Mastocytosis (AdvSM)
        • +3 more
        • CGT9486 tablets
        • Duarte, California
        • +10 more
        Jul 8, 2022

        Mastocytosis Trial in Toulouse (Hydroxychloroquine)

        Not yet recruiting
        • Mastocytosis
        • Toulouse, France
          Larrey Hospital - Toulouse University Hospital
        Oct 6, 2021

        High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

        Terminated
        • High-risk Myelodysplastic Syndromes
        • +3 more
        • GTB-3550 TriKE® Phase I
        • GTB-3550 TriKE® Phase II
        • Minneapolis, Minnesota
        • +1 more
        Mar 21, 2022

        Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

        Recruiting
        • Indolent Systemic Mastocytosis
        • Rochester, Minnesota
        • +6 more
        Nov 29, 2021

        Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor

        Approved for marketing
        • Advanced Systemic Mastocytosis
        • +3 more
        • (no location specified)
        Oct 5, 2021

        Avapritinib Versus Best Available Therapy in Patients With AdvSM

        Completed
        • Advanced Systemic Mastocytosis
        • +3 more
          • Palo Alto, California
          • +5 more
          Dec 17, 2021

          Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

          Recruiting
          • Leukemia, Acute Myeloid
          • +7 more
          • Denver, Colorado
          • +4 more
          Aug 29, 2022

          Pregnancy and Medically Assisted Conception in Rare Diseases

          Recruiting
          • Rheumatoid Arthritis
          • +10 more
            • Paris, France
              Hôpital Cochin
            Oct 31, 2022

            Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

            Active, not recruiting
            • Advanced Systemic Mastocytosis
            • +3 more
            • Stanford, California
            • +31 more
            Mar 25, 2022

            Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

            Recruiting
            • Indolent Systemic Mastocytosis
            • Monoclonal Mast Cell Activation Syndrome
            • Palo Alto, California
            • +33 more
            Jul 27, 2022

            Osteoporosis, Systemic Mastocytosis Trial in France (Denosumab, Placebo)

            Active, not recruiting
            • Osteoporosis
            • Systemic Mastocytosis
            • Besançon, France
            • +10 more
            Apr 13, 2021

            Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

            Recruiting
            • Recurrent Acute Leukemia
            • +16 more
            • Duarte, California
              City of Hope Medical Center
            Nov 22, 2022

            Indolent Systemic Mastocytosis Trial in Worldwide (Avapritinib, Placebo)

            Active, not recruiting
            • Indolent Systemic Mastocytosis
            • Birmingham, Alabama
            • +48 more
            Jan 19, 2022

            Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

            Active, not recruiting
            • Gastrointestinal Stromal Tumors
            • +2 more
            • Scottsdale, Arizona
            • +25 more
            Apr 16, 2021

            Use of Tamoxifen in Systemic Mastocytosis

            Completed
            • Systemic Mastocytosis
              • Rochester, Minnesota
                Mayo Clinic
              Apr 9, 2020

              Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

              Active, not recruiting
              • Myelofibrosis
              • Chronic Myelomonocytic Leukemia
              • Duarte, California
              • +9 more
              Jan 24, 2023

              Indolent Systemic Mastocytosis Trial in France, United States (Masitinib, Placebo, Best Supportive Care)

              Completed
              • Indolent Systemic Mastocytosis
              • Sacramento, California
              • +23 more
              Nov 29, 2019

              Study of Mast Cell Precursors

              Completed
              • Mastocytosis
              • Healthy Volunteer
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Nov 4, 2022